**Abstract**

**Objective:** There is limited evidence about the cardiovascular changes in absence epilepsy (AE). Ethosuximide (ETX), a T-type calcium channel blocker, is one of the most commonly used drug in AE treatment. But its effects on cardiovascular functions in AE also has not been investigated. This study aimed to investigate the efficacy of ETX treatment on absence seizures and its effect on potentially observable cardiovascular changes in genetic absence epileptic WAG/Rij rats.

**Method:** We divided 2-month-old Wistar and WAG/Rij rats into two groups (n=16): Control and ETX groups. The ETX groups were treated with ETX (orally, 300 mg/kg/day) for 3 months. Control groups received physiological saline. After 3 months; the number, mean duration and total duration of spike wave discharges (SWD) were evaluated using EEG recordings. Each group was then divided into two subgroups. In the first group mean arterial blood pressure (MAP) and heart rate (HR) measurements were performed. In the second group, *in vitro* isolated organ studies were conducted on the thoracic aortas of animals.

**Results:** ETX treatment significantly reduced the number, mean duration and total duration of SWDs in WAG/Rij rats compared to control group. Wistar groups did not have any SWD. In WAG/Rij control group, MAP was significantly higher than Wistar control. HR in Wistar ETX group was significantly lower than Wistar control group. KCl contraction responses increased in the Wistar ETX and decreased in the WAG/Rij control group compared to Wistar control group. Carbachol relaxation responses significantly increased in WAG/Rij control and decreased in Wistar ETX group compared to Wistar control group. There was no significant difference in sodium nitroprusside responses.

**Conclusions:** Cardiovascular function changes have been observed in the WAG/Rij rats with AE and as a result of ethosuximide treatment, indicating that T-type calcium channels may play a major role in these changes.
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